Molecular Formula | C9H7IO2S |
Molar Mass | 306.12 |
Solubility | DMSO: >20mg/mL |
Appearance | powder |
Color | yellowish |
Storage Condition | -20°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
In vitro study | PD150606 interacts with both calcium-binding domains (μ- and m-calpains) of Calpain. PD150606 attenuates hypoxic/hypoglycemic injury to cerebrocortical neurons in culture and excitotoxic injury to Purkinje cells in cerebellar slices. PD 150606 (25 μM; 0-12 hours) reduces Cycloheximide (10 mg/ml) -triggered apoptosis of neutrophils. |
Hazard Symbols | T - Toxic |
Risk Codes | R25 - Toxic if swallowed R37/38 - Irritating to respiratory system and skin. R41 - Risk of serious damage to eyes R43 - May cause sensitization by skin contact |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1 / PGIII |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.267 ml | 16.333 ml | 32.667 ml |
5 mM | 0.653 ml | 3.267 ml | 6.533 ml |
10 mM | 0.327 ml | 1.633 ml | 3.267 ml |
5 mM | 0.065 ml | 0.327 ml | 0.653 ml |
biological activity | PD 150606 is a selective, cell-permeable, non-peptide calpain inhibitor, the Ki for the effects of β-calpains and m-calpains were 0.21 μm and 0.37 μm, respectively, and showed neuroprotective activity. |
Target | Ki: 0.21 μm (δ-calpains), 0.37 μm (m-calpains) |